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Tumor cells use actin-rich protrusions called invadopodia to degrade extracellular matrix (ECM) and invade tissues;
related structures, termed podosomes, are sites of dynamic ECM interaction. We show here that supervillin (SV), a
peripheral membrane protein that binds F-actin and myosin II, reorganizes the actin cytoskeleton and potentiates
invadopodial function. Overexpressed SV induces redistribution of lamellipodial cortactin and lamellipodin/RAPH1/
PREL1 away from the cell periphery to internal sites and concomitantly increases the numbers of F-actin punctae. Most
punctae are highly dynamic and colocalize with the podosome/invadopodial proteins, cortactin, Tks5, and cdc42. Cortactin
binds SV sequences in vitro and contributes to the formation of enhanced green fluorescent protein (EGFP)-SV induced
punctae. SV localizes to the cores of Src-generated podosomes in COS-7 cells and with invadopodia inMDA-MB-231 cells.
EGFP-SV overexpression increases average numbers of ECM holes per cell; RNA interference-mediated knockdown of SV
decreases these numbers. Although SV knockdown alone has no effect, simultaneous down-regulation of SV and the
closely related protein gelsolin reduces invasion through ECM. Together, our results show that SV is a component of
podosomes and invadopodia and that SV plays a role in invadopodial function, perhaps as a mediator of cortactin
localization, activation state, and/or dynamics of metalloproteinases at the ventral cell surface.
INTRODUCTION
During metastasis, tumor cells invade the surrounding ex-
tracellular matrix (ECM), migrate into the bloodstream, and
traverse endothelial barriers at secondary sites in distant
organs (Condeelis et al., 2005). ECM degradation, in vitro,
involves specialized membrane-associated F-actin structures
known as podosomes and invadopodia (Weaver, 2006;
Linder, 2007; Gimona et al., 2008; Machesky et al., 2008).
Podosomes are endogenously found in cell types that cross
tissue boundaries or are involved in tissue remodeling, e.g.,
leukocytes and osteoclasts, respectively (Gimona et al., 2008).
Although podosomes contain many focal adhesion proteins
and may mediate dynamic cell–ECM attachments, they are
distinguishable from focal adhesions, which are ECM- and
integrin-associated complexes that promote cell migration in
fibroblasts (Zaidel-Bar et al., 2004; Evans and Matsudaira,
2006; Lo, 2006; Romer et al., 2006; Spinardi and Marchisio,
2006; Block et al., 2008; Broussard et al., 2008). Podosomes
turn over much faster than do focal adhesions and contain
cores of actin filaments that are surrounded by rings of
vinculin and other focal adhesion proteins (Gavazzi et al.,
1989; Ochoa et al., 2000; Destaing et al., 2003; Evans and
Matsudaira, 2006). Electron micrographs of podosomes in
Rous sarcoma virus-transformed fibroblasts show that the
dense microfilamentous material in the core surrounds a
central invaginating membrane tubule (Nitsch et al., 1989;
Ochoa et al., 2000). Invadopodia mediate ECM degradation,
are larger and longer-lived than podosomes, and are char-
acterized by surface protrusions and large membrane in-
vaginations (Chen and Wang, 1999; Baldassarre et al., 2003;
Yamaguchi and Condeelis, 2007; Stylli et al., 2008).
Recent studies indicate many functional and composi-
tional similarities between podosomes and invadopodia.
Both these structures have been associated with secretion of
matrix metalloproteinases (MMPs) and endocytosis of de-
graded matrix components (Ochoa et al., 2000; Baldassarre et
al., 2003; Clark and Weaver, 2008). Also, both structures
contain several proteins in common—including cortactin,
Tks5/FISH, and Cdc42—in addition to many proteins also
found at focal adhesions (Seals et al., 2005; Linder, 2007;
Yamaguchi and Condeelis, 2007; Block et al., 2008). Current
nomenclature is to use the term “invadopodia” for invasive
structures in tumor cells and to use “podosome” for the
invasive/adhesive structures in transformed fibroblasts and
in cells—such as leukocytes, osteoclasts, and endothelial and
smooth muscle cells—with endogenous or inducible podo-
somes (Gimona et al., 2008). However, vascular smooth mus-
cle cells invade ECM, and tumor cells contain podosome-
like, dynamic “preinvadopodial complexes” with short
lifetimes that mature into longer lived invadopodia
(Yamaguchi et al., 2005; Furmaniak-Kazmierczak et al., 2007).
In addition, invadopodium formation involves sequential
stages of cortactin recruitment to membranes, membrane
type (MT) 1–MMP accumulation, matrix degradation, and
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cortactin dissociation (Artym et al., 2006). Thus, the distinc-
tion between “podosomes” and “invadopodia” may be as
much temporal as compositional, i.e., invasion structures
may arise from more dynamic podosome-like precursors in
both normal tissues and tumors (Linder and Aepfelbacher,
2003; Gimona et al., 2008). Here, we use the current nomen-
clature for podosomes and invadopodia and refer to unde-
fined structures as “actin punctae.”
Supervillin (SV) is one of the largest members of the
villin/gelsolin family of actin-organizing proteins, which
have both overlapping and distinct functions (Silacci et al.,
2004; Archer et al., 2005; Khurana and George, 2008). Villin is
associated with precancerous morphological changes in ep-
ithelia, and gelsolin is required for the formation and deg-
radative activity of osteoclast podosomes; gelsolin also pro-
motes cancer cell invasion and motility (MacLennan et al.,
1999; Chellaiah et al., 2000; De Corte et al., 2002; Rieder et al.,
2005; Van den Abbeele et al., 2007). Nonmuscle SV copurifies
from neutrophil plasma membranes as a component of a
lipid raft-like complex that also includes heterotrimeric G
proteins, Src family kinases, and MT6-MMP (Nebl et al.,
2002), all of which are involved in tumorigenesis and matrix
degradation (Mareel and Leroy, 2003; Ingley, 2008; Sohail et
al., 2008). A smooth muscle isoform of SV, called SmAV,
localizes to phorbol ester-induced podosomes in A7r5 cells
with F-actin, nonmuscle myosin IIB, and extracellular sig-
nal-regulated kinases (ERKs) 1/2 (Gangopadhyay et al.,
2004). SmAV is required for normal ERK1/2 activation
downstream of phenylephrine signaling in ferret aorta
(Gangopadhyay et al., 2004), but the functionality of SV
isoforms in the formation of podosome-like structures has
not been explored.
Based on its biochemical characteristics, SV is well posi-
tioned for a role in mediating alterations in the actin cy-
toskeleton at membranes. SV cofractionates with mem-
branes and binds very tightly to the membrane bilayer,
resisting extraction with buffered solutions at pH 12
(Pestonjamasp et al., 1997; Nebl et al., 2002; Oh et al., 2003).
One site of membrane attachment is associated with SV
amino acids 342–571 (SV342-571), which interact with the
LIM domains of the focal adhesion proteins, thyroid recep-
tor-interacting protein (TRIP) 6/zyxin-related protein 1, and
lipoma-preferred partner (Takizawa et al., 2006). SV also
binds avidly to F-actin at three sites through which it can
either bundle or cross-link actin filaments; to nonmuscle
myosins IIA and IIB; to the long isoform of myosin light
chain kinase; and to calponin (Chen et al., 2003; Takizawa et
al., 2007), a negative regulator of podosome formation in
smooth muscle cells (Gimona et al., 2003).
SV potentiates a process that negatively regulates focal
adhesion function. Overexpressed SV decreases cell adhe-
sion to fibronectin, whereas RNA interference (RNAi)-me-
diated SV down-regulation increases cell attachment
(Takizawa et al., 2006). Sequences within the SV N terminus
(SV1-171) disrupt stress fibers by inducing apparent hyper-
contractility of myosin II (Takizawa et al., 2006, 2007). An-
other SV sequence (SV342-571) counteracts stress fiber and
large focal adhesion formation or stability through the in-
teraction with TRIP6 (Takizawa et al., 2006). However, phal-
loidin staining of cytoplasmic F-actin is observed even after
disruption of stress fibers in cells expressing elevated levels
of SV or SV342-571 (Wulfkuhle et al., 1999; Takizawa et al.,
2006). The nature of these phalloidin-stained structures has
never been explored.
The mechanism by which SV and TRIP6 regulate adhesion
also is imperfectly understood. Most investigations have
focused on the roles of these proteins in “inside-out” signal-
ing through other proteins on the cytoplasmic sides of focal
adhesions (Yi et al., 2002; Lai et al., 2005, 2007; Bai et al., 2007;
Takizawa et al., 2007). An alternative, nonmutually exclusive
hypothesis, tested in this study, is that SV induces the loss of
focal adhesion function by promoting the formation of po-
dosomes, invadopodia, and ECM degradation.
MATERIALS AND METHODS
Antibodies, Reagents, and Constructs
Mouse monoclonal anti-vinculin (hVIN1) and anti-gelsolin (clone GS-2C4)
antibodies were from Sigma-Aldrich (St. Louis MO), as was affinity-isolated
rabbit anti-hemagglutinin (HA) tag. Mouse monoclonal anti-cortactin (4F11)
and anti-actin (clone C4) antibodies were from Millipore (Billerica, MA).
Mouse monoclonal anti-phosphotyrosine (pTyr-100) and anti-myc (71D10)
antibodies were from Cell Signaling Technology (Danvers, MA). Mouse
monoclonal anti-phospho-focal adhesion kinase (FAK) (pY397) antibody was
from BD Biosciences (Franklin Lakes, NJ). AlexaFluor 488- and 568-conju-
gated secondary antibodies against rabbit and mouse immunoglobulin Gs
(IgGs), and fluorescein- and Texas Red-conjugated phalloidin were from
Invitrogen (Carlsbad, CA) and used at 1:2000 dilution. Affinity-purified rabbit
polyclonal antibodies against SV (H340) and lamellipodin (3917) have been
described previously (Krause et al., 2004; Nebl et al., 2002; Oh et al., 2003).
EGFP-C1 and EGFP-SV vectors were described previously (Wulfkuhle et al.,
1999). An untagged version of bovine SV was made by cloning the full-length
SV cDNA into the KpnI and XbaI sites of pTracer-CMV (Invitrogen) (Wulfku-
hle et al., 1999). His-tagged cortactin(SH3, amino acids 1–506) was generated
from pdsRed-cortactin (gifted by Dr. Alan S. Mak, Queen’s University, King-
ston, ON, Canada) (Webb et al., 2006a) after digestion with BglII and cloning
into pET30a vector (Invitrogen). Y527F-Src was from the Harold Varmus
laboratory (National Institutes of Health, Bethesda, MD). Myc-tagged Tks5
(myc-Tks5) (Lock et al., 1998) and HA-tagged Cdc42 (Shinjo et al., 1990)
(HA-Cdc42), both in the pEF-BOS expression vector (Mizushima and Nagata,
1990), were kind gifts from Drs. Sara Courtneidge (Burnham Institute for
Medical Research, La Jolla, CA) and Dr. Kozo Kaibuchi (Nagoya University,
Nagoya, Japan), respectively. EGFP-MT1-MMP was from Dr. Maria C. Mon-
toya (Spanish Nacional Cancer Research Center [CNIO], Madrid, Spain)
(Galvez et al., 2002; Bravo-Cordero et al., 2007).
Immunoblotting
Whole cell lysates were prepared in 1% SDS, phosphate-buffered saline (PBS),
1 mM phenylmethylsulfonyl fluoride (PMSF), and a protease inhibitor cock-
tail containing: 1 g/ml aprotinin, 1 M antipain, 2  ALLM (calpain
inhibitor II), 1 mM benzamidine, 10 M E64, 1 M leupeptin, and 1 M
pepstatin A. For each sample, 40 or 50 g of protein, as determined by
bicinchoninic acid protein assay (Pierce Chemical, Rockford, IL), were run on
SDS-polyacrylamide gels (Laemmli, 1970), transferred to nitrocellulose mem-
branes (Towbin et al., 1979), and probed with primary antibodies against
supervillin (0.2–0.4 g/ml) and gelsolin (1:5000); -actin (1:5000 antibody
dilution) was used as a loading control. Horseradish peroxidase-conjugated
goat anti-mouse or goat anti-rabbit secondary antibodies (Jackson Immu-
noResearch Laboratories, West Grove, PA), diluted 1:20,000, were detected by
Pierce SuperSignal WestPico chemiluminescence. Band densities were deter-
mined using ImageJ (Rasband, National Institutes of Health, Bethesda, MD;
http://rsb.info.nih.gov/ij/). EGFP-SV expression levels were determined by
comparing band intensities with endogenous SV and correcting for transfec-
tion efficiency.
Cell Culture and Transfection
COS7-2 cells, a highly transfectable clone of COS7 (Kowalczyk et al., 1997),
were a generous gift from Dr. Kathleen J. Green (Northwestern University,
IL). COS7 cells were grown in high glucose DMEM (11995; Invitrogen)
supplemented with 10% fetal calf serum (FCS) for 20 passages. MDA-MB-
231 breast carcinoma cells were obtained from American Type Culture Col-
lection (Manassas, VA) and from the Tissue Culture Shared Resource of the
Lombardi Cancer Center (courtesy of Dr. Susette Mueller, Georgetown Uni-
versity, Washington, DC). G418-resistant MDA-MB-231 cells that stably over-
express wild-type c-Src (MDA-MB-231/WT Src cells) were a kind gift from
Dr. Toshiyuki Yoneda (University of Texas Health Science Center, San Anto-
nio, TX) and Dr. S. Mueller (Myoui et al., 2003; Bowden et al., 2006). MDA-
MB-231 cells without and with WT c-Src overexpression were grown in
DMEM supplemented with 10% FCS and 2 mM l-glutamine (25030; Invitro-
gen). Cultured cells for immunoblots were generously supplied by Drs. G.
Sluder (primary human foreskin fibroblasts and hTERT-RPE1; Clontech,
Mountain View, CA), L. Languino (LNCaP), K. C. Balaji (LNCaP, C4-2, and
DU-145), and A. Mercurio (MCF10A series), all from University of Massachu-
setts Medical School.
Transfection methods have been described previously (Takizawa et al.,
2006). Briefly, for plasmids, COS7 cells were transfected using Effectene
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Transfection Reagent (QIAGEN, Valencia, CA) for 24 h with the Y527F-Src,
HA-Cdc42, and myc-Tks5 plasmids or for 24 or 48 h with the EGFP-SV
plasmid. For small interfering RNAs (siRNAs), COS7 cells were transfected
with Lipofectamine 2000 (Invitrogen). MDA-MB-231/WT Src cells were trans-
fected using the Nucleofector system (Amaxa Biosystems, Gaithersburg, MD),
according to manufacturer’s instructions. Briefly, for each Nucleofection, 1 106
adherent cells were trypsinized, rinsed with Dulbecco’s PBS, modified (14190;
Invitrogen), resuspended with 100 l of solution V and with either 40 nM
Stealth siRNA or 2 g of plasmid, and treated using program X13. Cells
treated with siRNA were incubated for 4 d before experiments, whereas cells
treated with plasmid were incubated for 2 d.
The double-stranded (ds)RNAs targeting COS7 cell SV have been described
previously (Takizawa et al., 2007). Two dsRNAs targeting human SV were made
as Stealth duplexes (Invitrogen): human (h)SV1, 5-CAGCCAUAAGGAAUC-
UAAAUAUGCU-3 (coding nucleotides 1680-1704); and hSV2, 5-GCGAU-
GUUUGCUGCUGGAGAGAUCA-3 (coding nucleotides 2026-2050). The
Stealth duplex sequence 5-GAACUAUGAAGGACCACCAGAGAUA-3 was
used as a control dsRNA. A dsRNA targeting human gelsolin was also made as
a Stealth Duplex with the sequence 5-CAGTTCTATGGAGGCGACAGC-
TACA-3 (coding nucleotides 1460-1484). Two dsRNAs targeting primate cortac-
tins were made as Stealth duplexes: CT1 5-UCUUGUUCCACACCAAAUUUC-
CCUC-3 and CT2 5-GAGGGAAAUUUGGUGUGGAACAAGA-3.
Recombinant Protein Purification and in Vitro Pull-Down
Assay
Glutathione transferase (GST)-SV fusion fragment proteins were expressed
after isopropyl -d-thiogalactoside (IPTG) induction in BL21(DE3)pLysS cells
and purified with glutathione-Sepharose as described previously (Chen et al.,
2003). His-cortactin(SH3) was expressed after induction by IPTG and puri-
fied by using nickel-nitrilotriacetic acid Agarose (QIAGEN). Eluted proteins
were dialyzed in dialysis buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1 mM
dithiothtreitol [DTT], and 10% glycerol). Dialyzed proteins were frozen
quickly in liquid nitrogen and stored at 80°C.
Purified GST-SV fragments were mixed with His-cortactin(SH3) in bind-
ing buffer (50 mM Tris, pH 8.0, 300 mM NaCl, 1% Triton X-100, 1 mM DTT,
10% glycerol, 1 mM PMSF, and protease inhibitor cocktail) and incubated
with glutathione-Sepharose beads for 1 h at 4°C with shaking. The mixtures
were then washed five times with binding buffer followed by centrifugation
at 3000 rpm for 2 min. Beads were resuspended in 2 SDS sample buffer and
heated to 95°C for 5 min. Proteins were separated by SDS-PAGE and trans-
ferred to a nitrocellulose membrane. His-cortactin(SH3) was identified by
immunoblotting with monoclonal anti-His antibody (clone 27E8; Cell Signal-
ing Technology).
Live Cell Imaging
COS7 cells transfected with EGFP-SV were cultured on 22-mm square cov-
erslips and sealed into chambers with DMEM, 10% FCS, and 10 mM HEPES,
without phenol red. After temperature equilibration in a Plexiglas environ-
mental chamber heated to 37°C, images focused on the ventral cell surface
were acquired for EGFP, by using an HCX PL Apo 63 1.32 numerical
aperture (NA) oil immersion objective lens on a DMIRE 2 inverted micro-
scope (Leica Microsystems, Allendale, NJ), a Retiga Exi cooled charge-cou-
pled device (CCD) camera (QImaging Corp., Burnsby BC, Canada), and
OpenLab 3.5.2 software (Improvision, Waltham, MA). Images were processed
with OpenLab to enhance contrast and to generate movie files. Labels and
movie titles were added with Adobe Photoshop (Adobe Systems, San Jose,
CA) and QuickTime Pro (Apple, Cupertino, CA).
Immunofluorescence
Cells were fixed for 10 min with 4% paraformaldehyde in PBS and perme-
abilized for 5 min with 0.2% Triton X-100 in PBS before blocking for 30 min
with 1% bovine serum albumin (BSA), 0.5% Tween 20 in PBS and immuno-
staining. Depending on the experiment, cells were stained for cortactin (1:200
dilution), phosphotyrosine (pTyr; 1:100), myc (1:200), HA (1:100), vinculin
(1:200), phosphorylated FAK 397 (pFAK; 1:100), -actinin (1:200), and/or
anti-SV (1:200). F-actin was visualized with phalloidin conjugated to Texas
Red or fluorescein (Invitrogen). Slides were analyzed with a 40 or 100
Plan-NeoFluor oil immersion objective (NA 1.3) on a Zeiss Axioskop fluores-
cence microscope, a RETIGA CCD camera (QImaging), and OpenLab 3.5.2
software (Improvision). Images were adjusted for contrast and brightness,
and merged images were assembled using Adobe Photoshop software
(Adobe Systems). For Z-series, images were acquired with a 100HCX PLAN
APO objective lens (NA 1.35) by using step sizes of 0.2 m on a DM IRE 2
inverted Leica microscope (Leica Microsystems, Bannockburn, IL) with a
Retiga Exi cooled CCD camera (QImaging) and OpenLab software. Images
were deconvolved using Volocity software (Improvision). Z-series also were
obtained with a 100 Plan Apo objective lens (NA 1.4) by using a Solamere
CSU10 spinning disk confocal microscope (Solamere Technical Group, Salt
Lake City, UT) on a Nikon Eclipse TE-2000 microscope (Nikon Instruments,
Melville, NY) and a Roper Scientific CoolSNAP HQ2 camera (Photometrics,
Tucson, AZ).
Gelatin-coated Coverslips
The preparation of fluorescently labeled gelatin-coated coverslips was carried
out as described previously (Bowden et al., 2001). Briefly, 2.5% gelatin, 225
bloom (type B; Sigma-Aldrich) was conjugated with tetramethylrhodamine-
5(and-6)-isothiocyanate ([TRITC] T-490; Invitrogen), dialyzed extensively to re-
move unbound dye, and stored in PBS with 2% sucrose. TRITC-gelatin (200 l)
was heated to 45°C and spread on ethanol-cleaned coverslips (22-mm square).
Excess gelatin was removed, and coverslips were inverted onto chilled 0.5%
glutaraldehyde in PBS for 15 min. Coverslips were then washed with PBS, and
unreacted aldehyde groups were quenched with 5 mg/ml sodium borohydride
for 5–10 min. After washing with PBS, coverslips were then sterilized briefly with
70% ethanol and incubated at 37°C in serum-free DMEM for 1 h before plating
cells. Cells in complete DMEM then were incubated for 6 h on the gelatin and
fixed with 4% paraformaldehyde, as described above.
Matrigel Invasion Assays
Cell invasion assays were performed using BioCoat Matrigel invasion cham-
bers (354480; BD Biosciences), according to the manufacturer’s instructions.
Briefly, 5  104 siRNA-treated MDA-MB-231/WT Src cells in serum-free
DMEM were added to the upper wells of invasion chambers that contained
DMEM with 10% serum in the bottom wells. Cells were allowed to migrate
for 20 h, and then cells remaining on the top side of the filter were removed
with moistened cotton swabs. Migrated cells were fixed and stained with the
HEMA 3 Stain Set (Fisher Scientific, Kalamazoo, MI). Five representative
images were taken from each insert with 10 magnification. Cells from the
Matrigel inserts were counted using the Cell Counterplugin for ImageJ. Cells
from control inserts were counted using the Analyze Particles command in
ImageJ after using the Threshold and Watershed commands to identify indi-
vidual cells. Invasion indices were determined as ratios of cells migrating in
the presence versus absence of Matrigel to control for changes in cell motility
and by normalizing experimental invasion indices against the mean value
obtained for cells treated with control siRNA.
Fluorescence-activated Cell Sorting (FACS) Analyses
The total amounts of cortactin in COS7 cells expressing EGFP or EGFP-SV
were assayed after lifting 1  106 cells from plates with 0.1% trypsin, 0.4
mg/ml EDTA. The cells were washed twice with PBS and fixed with 2%
paraformaldehyde in PBS for 20 min at room temperature with rotation in a
1.5-ml tube. Fixed cells were washed once and made permeable with 0.1%
Triton X-100 in PBS for 5 min at room temperature with rotation. After
blocking for 30 min with sterile-filtered 4% FBS, 0.05% sodium azide, PBS, the
cells were incubated for another 30 min on ice in blocking buffer containing
either 0.67 g/ml mouse anti-cortactin antibody or control mouse IgG1
(Leinco Technologies, St. Louis, MO). Cells were washed three times with
blocking buffer and then incubated for 15 min on ice with secondary antibody,
AlexaFluor 647-conjugated goat anti-mouse IgG F(ab2) (1:5000; Invitrogen).
The cells were washed three times with blocking buffer and resuspended into
0.5 ml of PBS containing 0.5% BSA in Falcon tubes for FACS analysis.
Statistical Analyses
Statistical significance was assessed using InStat 3 for Macintosh (GraphPad
Software, San Diego, CA). Unless otherwise stated, two-tailed p values were
determined by one-way analysis of variance with a Tukey–Kramer or Stu-
dent–Newman–Keuls multiple comparisons post test. As noted in figure
legends, some pairs of groups also were compared using unpaired t tests.
RESULTS
SV Promotes Restructuring of the Actin Cytoskeleton
SV Overexpression Increases F-Actin Punctae. Increased
levels of SV decrease the numbers of COS7 cells containing
stress fibers (Takizawa et al., 2006). Compared with overex-
pressed EGFP alone (Figure 1A, a–c), overexpression of
either EGFP-tagged SV (EGFP-SV) (Figure 1A, d–f) or un-
tagged SV (Figure 1A, g–i) increases the numbers of F-actin
punctae (Figure 1A, e and h vs. b, insets). These punctae,
which are 0.5 m in diameter, can be either round or
irregularly shaped. They are prominent at the ventral sur-
faces of cells expressing EGFP-SV but are also found near
nuclei, especially in EGFP-expressing control cells (Supple-
mental Figure S1). In wide-field fluorescence (Figure 1A),
the mean numbers of ventral F-actin punctae in cells ex-
pressing EGFP-SV (Figure 1B) or untagged SV (Figure 1C)
increase approximately sevenfold, compared with mock-
transfected cells or cells expressing only EGFP, indicating
J. L. Crowley et al.
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specificity for SV sequences. The increase in ventral F-actin
punctae in EGFP-SV–transfected cells was not due solely to
protein expression levels because even with very high ex-
pression of EGFP, the number of these punctae does not
increase to levels seen with EGFP-SV (Figure 1D). This in-
crease in ventral F-actin punctae is apparently a gain of
function because RNAi-mediated reduction of endogenous
SV to 20  5% of normal levels does not significantly
reduce the low background numbers of F-actin punctae in
COS7 cells (data not shown).
Most EGFP-SV Punctae Are Dynamic, but These Structures
Are Probably Heterogeneous in Nature. In live cell imaging,
94% of the EGFP-SV punctae in the cell periphery were
highly dynamic and short lived (Figure 2 and Supplemental
Video 1). Although occasional movements of 1.0 m/s
were seen, the instantaneous velocities of these punctae
averaged 0.36 0.05 m/s (mean SEM; n	 19) over their
lifetimes of 2.9  0.3 min (mean  SEM, n 	 93) (Figure 2,
A and B). These dynamic short-lived punctae moved both
toward and away from the cell periphery (Figure 2A, arrow-
heads; and Supplemental Video 1). The6% of the EGFP-SV
punctae that were longer lived exhibited lifetimes of at least
30.5  1.6 min (mean  SEM; n 	 6) (Figure 2B) and were
largely restricted in localization (Figure 2C), with signal
intensities that could vary over time (Figure 2A, double
arrows). Other longer lived punctae tumbled in place, as
though they might be associated with larger, vesicular struc-
tures and exhibited sporadic, rapid movements (Figure 2A,
arrow; and C). The mean instantaneous velocity of EGFP-SV
punctae is most consistent with directional movements pro-
pelled by kinesins (0.5 m/s), but the variable direction-
alities and the range of observed velocities suggest the pos-
sibility of multiple propulsion mechanisms, including actin
comet tails (0.17 m/s), myosin Vb (0.22 m/s), and dy-
nein (0.9 m/s) (Porter et al., 1987; Woehlke et al., 1997;
Benesch et al., 2002; Toba and Toyoshima, 2004; Paluch et al.,
2006; Watanabe et al., 2006).
EGFP-SV Punctae Contain Podosome Markers, but Not
Focal Adhesion Proteins. The lifetimes and dynamic be-
havior of most EGFP-SV punctae are reminiscent of po-
dosomes or invadopodial precursors (Yamaguchi et al.,
2005; Evans and Matsudaira, 2006). Although the local-
Figure 1. Overexpression of EGFP-SV in
COS7 cells increases the numbers of cytoplas-
mic F-actin punctae. (A) COS7 cells were trans-
fected for 48 h with vectors encoding EGFP
(a–c), EGFP-SV (d–f), or GFP plus untagged
supervillin (g–i). Cells were fixed and stained
for F-actin using Texas Red phalloidin (b, e, and
h). Bar, 20 m. Insets enlarged fourfold. Over-
lap in white. (B and C) F-actin punctae were
counted in untransfected cells after a mock
treatment with transfection agent alone, or in
cells expressing EGFP, EGFP-SV, or GFP as a
marker for untagged SV. Distributions of indi-
vidual counts and their means are shown. Both
EGFP-SV and untagged SV differed from con-
trols, p  0.001, n 	 25–28/group. (D) The
relative amounts of EGFP (closed symbols) or
EGFP-SV (open symbols) in individual cells
were estimated from total luminosities of wide-
field microscopic images. The plot shows the
number of F-actin punctae per cell versus lumi-
nosity. EGFP-SV expression levels were 12.5 
0.7 (mean  SD; n 	 3) times that of endoge-
nous SV. At these expression levels, no signifi-
cant trend was detected for either data set.
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ization of some punctae above the ventral cell surface
(Supplemental Figure 1) argues against a 1:1 identity with
podosomes, most ventral EGFP-SV punctae do colocalize
with podosome/invadopodial proteins (Figure 3). For ex-
ample, 91% of the EGFP-SV punctae colocalize with
endogenous cortactin (Figure 3, A–C, boxes), a protein
required for the formation and function of invadopodia
(Bowden et al., 1999; Artym et al., 2006; Clark et al., 2007;
Ayala et al., 2008; Clark and Weaver, 2008). Also, 75 and
50%, respectively, of the EGFP-SV punctae associate
with coexpressed myc-Tks5/FISH (Figure 3, D–F) and
HA-Cdc42 (Figure 3, G–I), other proteins important for
invadopodial function (Nakahara et al., 2003; Courtneidge
et al., 2005; Yamaguchi et al., 2005). Approximately 27% of
the EGFP-SV punctae contain endogenous phosphoty-
rosine (Figure 3, J–L), a marker for invadopodia, tyrosine
kinase-associated intracellular vesicles, and focal adhe-
sions (Zamir et al., 1999; Bowden et al., 2006; Sandilands
and Frame, 2008). By contrast, only 3 or 5%, respec-
tively, of the EGFP-SV punctae colocalize with vinculin or
pFAK (Figure 3, M–R), focal adhesion proteins that are
present as rings in podosomes but absent from most
invadopodia (Bowden et al., 2006; Machesky et al., 2008).
Most of the overlap between EGFP-SV and vinculin and
pFAK is at focal adhesions, as reported previously (Figure
3, M–R, arrows) (Wulfkuhle et al., 1999; Takizawa et al.,
2006).
SV Causes a Redistribution of Cortactin. Because EGFP-SV
reorganizes F-actin and overlaps extensively at punctae with
cortactin, a protein that organizes actin at lamellipodial ruf-
fles and is required for podosomes and invadopodia (Buday
and Downward, 2007; Ammer and Weed, 2008; Weaver, 2008),
we investigated cortactin localization in cells expressing
EGFP-SV (Figure 4). In mock-transfected cells and in cells
expressing EGFP alone for 48 h, 70% (50–109 cells/experi-
ment; n 	 3) of the cells exhibit areas of contiguous, 20-m-
long cortactin staining at their peripheries (Figure 4A, arrow-
heads; and B), as described originally (Wu and Parsons, 1993).
By contrast, only 33.1  5.7% (50 cells/experiment; n 	 6;
p  0.0001) of cells overexpressing EGFP-SV contained strong
contiguous peripheral cortactin staining by 48 h after transfec-
tion (Figure 4A, d–f, arrows; and B); slight decreases were
observed after only 24 h (data not shown). Cortactin was
apparently redistributed to the cell interior, as opposed to
being differentially stabilized or cleaved by calpain (Perrin et
al., 2006), because FACS analyses showed no changes in total
amounts of cellular cortactin with increasing expression of
either EGFP or EGFP-SV (Figure 4C).
Other Lamellipodial Markers Also Are Displaced. To deter-
mine whether EGFP-SV promotes the selective redistribution
of cortactin, we also monitored two other proteins characteris-
tically concentrated at lamellipodia, lamellipodin/RAPH1/
PREL1 (Figure 5, A–C) (Krause et al., 2004) and filamin
Figure 2. Most EGFP-SV punctae are dynamic and short lived; a few are longer lived and relatively stable. (A) Time-lapse sequence of
EGFP-SV punctae in COS7 cells on glass coverslips from Supplemental Video 1. Images were taken every 12 s for 60 min. Bar, 10 m.
Examples of short-lived (arrowheads) and long-lived (arrows) punctae are indicated. (B) Distribution of individual punctae lifetimes; n 	 99.
(C) Sample trajectories of EGFP-SV punctae with associated lifetimes.
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A/ABP280 (Figure 5D-F) (Stendahl et al., 1980). EGFP-SV in-
duces a significant loss of lamellipodin from the cell periphery
(Figure 5, A and B). By contrast, filamin remains at the cell
periphery in COS7 cells expressing EGFP-SV, but the extent
and intensity of the peripheral filamin signal seems reduced
(Figure 5, D and E). Unlike the nearly perfect overlap seen with
cortactin antibody (Figure 3, A–C), most EGFP-SV punctae lack
lamellipodin and filamin (Figure 5, C and F, arrowheads), with
only 38 and 35%, respectively, of the EGFP-SV punctae
overlapping with signal from antibodies against these two
proteins (Figure 5, C and F, arrows).
Cortactin Binds SV In Vitro. Due to the redistribution of
cortactin upon EGFP-SV overexpression (Figure 4) and the
Figure 3. EGFP-SV punctae colocalize with
cortactin and exogenous Tks5 and Cdc42 but
not with phospho-FAK or vinculin. COS7 cells
expressing EGFP-SV (A, D, G, J, M, and P) were
stained with antibodies against endogenous
cortactin (B), phosphotyrosine (pTyr; K), vincu-
lin (N), or phosphorylated FAK (pFAK; Q) or
with antibodies against tags on exogenously
expressed Tks5 (E) or Cdc42 (H). EGFP-SV is
green in the merged images (C, F, I, L, O, and
R); other proteins are shown in magenta; over-
lap is white. Insets, fourfold enlargements of
areas within boxes. Arrows denote focal adhe-
sions. Bar, 10 m.
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striking amount of colocalization of the two proteins (Fig-
ure 3, A–C), compared with the relatively weak overlap
with lamellipodin and filamin (Figure 5, C and F), we
investigated whether cortactin binds SV directly. GST or
GST-tagged SV N-terminal fragments were mixed with
His-cortactin(SH3), and interacting proteins were co-
sedimented with glutathione-Sepharose beads (Figure
6A). Even with significant His-cortactin(SH3) input (Figure
6A, a and b, lanes 1), there was no detectable binding with
GST or beads only (lanes 2 and 3). His-cortactin(SH3) was
pulled down with SV amino acids SV1-340 (lanes 4), SV570-
830 (lanes 7), and SV340-830 (lanes 8). The lack of binding
with SV171-340 (lanes 5) or SV340-570 (lanes 6) indicates
likely cortactin binding sequences within SV1-171 and
SV570-830.
Cortactin Increases the Numbers of EGFP-SV F-Actin Punctae.
To see whether cortactin is necessary for the formation of
EGFP-SV–induced F-actin punctae, we reduced cortactin
levels by 74% of control-treated cells (Figure 6B, CON, lane
1) by using two different cortactin-specific siRNAs (CT1 and
CT2; lanes 2 and 3). Cortactin knockdown cells were trans-
fected with plasmids encoding EGFP or EGFP-SV and
scored for the number of F-actin punctae (Figure 6C). As in
the absence of siRNA treatment (Figure 1), there is a signif-
icant difference between EGFP- and EGFP-SV–transfected
cells treated with the control siRNA (***p  0.001) (Figure
6C). Although cortactin knockdown has no significant effect
on the numbers of F-actin punctae in EGFP-transfected cells,
the reduction in cortactin levels inhibits 50% of the in-
crease in numbers induced by EGFP-SV (*p  0.05). There-
fore, the podosome and invadopodial protein cortactin con-
tributes to the formation of EGFP-SV punctae.
Role of SV at Podosomes and Invadopodia
Endogenous SV Localizes to Src-induced Podosomes and
Areas of Matrix Degradation in COS7 cells. To further
examine the relationship between SV and podosomes/inva-
dopodia, we localized endogenous SV in COS7 cells contain-
ing podosomes induced by constitutively active c-Src-Y527F
(Figure 7). Each Src-induced podosome consists of a core of
F-actin, cortactin, and other proteins surrounded by a ring of
focal adhesion proteins (Linder and Aepfelbacher, 2003).
Endogenous SV colocalizes extensively with F-actin and
cortactin at the podosome cores (Figure 7, A and B) and less
Figure 4. Expression of EGFP-SV leads to redistribution of cortactin. (A) COS7 cells expressing EGFP alone (a; green in c) or EGFP-SV (d;
green in f) for 48 h were immunostained for endogenous cortactin (b and e; red in c and f). Cells were scored as containing (arrowheads) or
lacking (arrows) peripheral cortactin. Bar, 50 m. (B) Percentages of cells with continuous peripheral cortactin staining 48 h after mock
transfection (Mock) or expression of EGFP alone (EGFP) or EGFP-SV (EGFP-SV). Means  SD; ***p  0.0001. (C) Two-color FACS analyses
showing no change in the levels of total cellular cortactin caused by expression of EGFP or EGFP-SV in COS7 cells. Control, secondary
antibody alone.
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well with -actinin (Figure 7C), which associates with both
the podosome core and ring (Linder and Aepfelbacher,
2003). Little overlap of SV with the focal adhesion proteins,
phosphorylated FAK and vinculin, is observed in podosome
rings (Figure 7, D and E). The overall SV staining pattern at
podosome cores is generally more punctate than those of the
other proteins (Figure 7, left, x-y inset), although foci of SV
and cortactin show frequent overlaps (Figure 7B). Immuno-
localization of SV shows a preferential exposure of the SV
epitope at the apical ends of the podosomes, near the inter-
face with the cytoplasm (Figure 7), regardless of whether SV
is imaged with green (Figure 7) or red (Supplemental Figure
S2A and S2B) fluorophores. However, colocalization of
EGFP-SV and antibody-stained SV indicates that the N-
terminal epitope recognized by the antibody is preferentially
shielded near the base of the podosome cores (Supplemental
Figure S2C). Thus, as has been reported for the transmem-
brane receptor CD44 (Chabadel et al., 2007), the peripheral
membrane protein SV marks podosome cores. EGFP-SV also
localizes to areas of matrix degradation in COS7 cells on
fluorescently labeled gelatin although these cells do not
efficiently degrade matrix (Supplemental Figure S3).
Many Tumor Cell Lines Contain Relatively High Levels of
SV. To identify an invasive cell line in which we could
examine SV function in matrix degradation and invasion, we
screened a number of tumor cell lines for the presence of
endogenous SV. Abundant levels of SV message have been
reported in HeLa cervical adenocarcinoma, SW480 colorec-
tal adenocarcinoma, and A549 lung carcinoma cells (Pope et
al., 1998). In agreement with previous results (Pestonjamasp
et al., 1997), we find that HeLa cells contain higher levels of
endogenous SV than do untransformed cell lines (Supple-
mental Figure S4A, lanes 1–3). Several human prostate (LN-
CaP and C4-2, DU-145) (Stone et al., 1978; Thalmann et al.,
1994) and breast (MCF10A1, MCF10AT1k.cl2, MCL10CA1h,
MCF10ACA1a.cl1, and MDA-MB-231) (Tang et al., 2003)
epithelial cell lines contain abundant endogenous SV (Sup-
plemental Figure S4). The highest SV levels were seen in
MDA-MB-231 metastatic breast carcinoma cells, which in-
herently form invadopodia on ECM substrates (Chen et al.,
1994).
Endogenous SV Localizes to Invadopodia in MDA-MB-231
Cells. In MDA-MB-231 cells on gelatin, endogenous SV co-
localizes with the large ventral accumulations of cortactin
and F-actin characteristic of invadopodia (Figure 8A; Artym
et al., 2006). In addition, mRFP-SV is found in proximity with
45% of the vesicles or invadopodia that contain EGFP-
MT1-MMP (Figure 8B), the membrane-bound MMP respon-
sible for most matrix degradation in MDA-MB-231 cells
(Artym et al., 2006). Endogenous SV also is concentrated at
and within regions of matrix degradation, as identified by
black areas in thin films of TRITC-labeled gelatin (Figure
8C). In XZ and YZ views, SV is seen both within and above
the holes in the gelatin matrix created by invadopodia (Fig-
ure 8C, a–d). By contrast, little overlap is seen between
EGFP-SV and the pY-100 phosphotyrosine antibody (Bow-
den et al., 2006; Supplemental Figure S5). Together, these
data support an association between SV and invadopodia.
SV Overexpression Increases the Numbers of Matrix Degra-
dation Sites Formed Per Cell. We tested whether SV affects
ECM degradation in highly invasive MDA-MB-231 cells that
Figure 5. EGFP-SV redistributes lamellipo-
din/RAPH1/PREL1, but not filamin A, within
24 h. (A and D) COS7 cells expressing EGFP
alone (a) or EGFP-SV (c) for 24 h were immu-
nostained for endogenous lamellipodin (b and
d in A) or filamin A (b and d in D). Cells were
scored as containing (arrowheads) or lacking
(arrows) peripherally localized protein. Bars, 50
m. Percentages of cells with peripheral (B)
lamellipodin or (E) filamin staining 24 h after
mock transfection (Mock) or expression of
EGFP alone (EGFP) or EGFP-SV (EGFP-SV).
Means  SD; *p  0.05; n 	 2 (B); n 	 3 (E).
Overlap (arrows) or lack of overlap (arrow-
heads) of EGFP-SV punctae with endogenous
lamellipodin (C) and filamin (F). Bars, 20 m.
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stably overexpress WT Src (MDA-MB-231/WT Src) (Myoui
et al., 2003; Bowden et al., 2006). Transient overexpression of
EGFP-SV to levels that were 4.9  1.5 (mean  SD; n 	 3)
times greater than endogenous SV levels doubled the aver-
age number of holes per cell in the fluorescent gelatin matrix
(Figure 9B vs. A and C; and D). However, the percentage of
cells that made holes did not differ significantly from con-
trols (Figure 9E). Similar results are seen with MDA-MB-231
cells not transfected with c-Src (Supplemental Figure S6).
This SV-promoted increase in the numbers of holes per cell
corresponds to a 4.2-fold increase in the mean area of de-
graded matrix per cell (Supplemental Figure S7). These re-
sults are consistent with a SV-mediated increase in the num-
bers, efficiency, or dynamics of sites of ECM degradation.
SV Underexpression Decreases Matrix Degradation,
Especially in the Cell Center. Conversely, reduction of en-
dogenous SV levels reduces the apparent numbers of ECM-
degrading sites (Figure 10). Each of two siRNAs reduces SV
levels in MDA-MB-231/WT Src cells to 30% of endoge-
nous levels without adversely affecting the expression level
of the related protein, gelsolin (Figure 10A, lanes 1–2 vs. lane
3). Although these reduced levels of SV do not affect the
percentages of cells associated with degraded matrix (Figure
10B), the mean numbers of holes per cell (Figure 10C) and
the percentages of cells with holes underneath the central
region of the cell are decreased, compared with cells treated
with a control siRNA (Figure 10D; and E, e vs. b). By
contrast, matrix degradation in these assays is unaffected by
down-regulation of gelsolin (Figure 10A, lane 4; and B–D),
an SV family member involved in podosome assembly in
osteoclasts and matrix invasion of MDA-MB-231 cells (Chel-
laiah et al., 2000; Van den Abbeele et al., 2007). Double
knockdowns of SV and gelsolin (Figure 10A, lane 5) result in
Figure 6. Cortactin binds SV in vitro and contributes to the forma-
tion of EGFP-SV–induced punctae in vivo. (A) His-cortactin(SH3)
(input, lane 1) was mixed with glutathione-Sepharose beads and the
indicated GST fusion proteins (lanes 2 and 4–8) or with glutathione-
Sepharose beads alone (lane 3) for 1 h. Beads were washed, pelleted,
and heated in SDS sample buffer and interacting proteins were sub-
jected to SDS-polyacrylamide gel electrophoresis and stained with
Coomassie blue (a) or transferred to nitrocellulose and immunoblotted
for the His tag (b) (n 	 3). Arrowhead denotes His-cortactin(SH3).
Input lane (a) was digitally moved to match immunoblot (b). (B)
Cortactin protein levels in COS7 cells 4 d after transfection with control
siRNA (CON, lane 1) or cortactin siRNA (CT1, CT2, lanes 2, 3). -actin
was the loading control. Percent of cortactin remaining is shown under
cortactin bands (n 	 1). (C) Cortactin knockdown cells were trans-
fected with plasmids encoding EGFP or EGFP-SV at day 3 of siRNA
treatment, and F-actin punctae were visualized with phalloidin after an
additional 24 h (n 	 3). Statistically significant differences were deter-
mined by unpaired two-tailed Student’s t tests and with the Student-
Newman-Keuls multiple comparison test (*p  0.05, ***p  0.001).
Figure 7. Endogenous supervillin localizes to the cores of Src-
induced podosomes. COS7 cells were transfected with Y527F Src,
immunostained for SV, and stained for F-actin with phalloidin (A)
or with antibody against endogenous cortactin (B), -actinin (C),
pFAK (D), or vinculin (E) and visualized after deconvolution of
images acquired with 0.2-m Z-steps. F-actin and cortactin localize
to podosome cores, -actinin to cores 
 rings, and vinculin and
pFAK to podosome rings (Linder and Aepfelbacher, 2003). Individ-
ual podosomes in the XY view (arrowheads) have been enlarged to
the same scale as the XZ and YZ views. SV, green; other proteins
magenta; and overlaps in white. Bars, 10 micrometers in main
image, 1 m in inset.
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the same number of total holes per cell as observed for
controls (Figure 10C) and are not significantly more effective
than knockdown of SV alone in decreasing the presence of
central holes (Figure 10D). However, the locations of the
holes in the matrix for the SV/gelsolin double knockdown
tended to be shifted away from the cell centers toward the
cell edges, as was also observed for knockdown of SV alone
(Figure 10Eh). Thus, SV apparently affects both the numbers
and locations of the holes in the fluorescent matrix.
SV Knockdown Does Not Decrease Ventral F-Actin Punctae.
Although SV can increase F-actin bundling in vitro and in
vivo (Wulfkuhle et al., 1999; Chen et al., 2003), SV probably
is not required for the formation of ventral F-actin structures
(Figure 10E). MDA-MB-231/WT Src cells with reduced lev-
els of SV and significantly reduced sites of matrix degrada-
tion (Figure 10E, e, h vs. b) still contain apparently normal
levels of F-actin structures within the ventral focal plane
(Figure 10E, d, g vs. a). In addition, COS7 cells expressing
constitutively active c-Src-Y527F form similar numbers of
podosomes, regardless of whether their SV levels are normal
or have been reduced to 20  5% of endogenous levels
(Supplemental Figure S8). The normal-looking appearance
of the ventral F-actin structures in SV knockdown cells,
coupled with the reduced numbers of associated ECM holes
in MDA-MB-231/WT Src cells, suggest a defect in invadopo-
dial function.
SV Knockdown Reduces Invasion, but Only in the Con-
text of Reduced Levels of Gelsolin. As a direct assay for
the roles of SV and gelsolin in invasion, we measured the
effects of single and double SV and gelsolin knockdowns on
the ability of MDA-MB-231/WT Src cells to invade Matrigel-
coated transwell filters (Figure 11). Invasion indices are nor-
malized to eliminate effects of changes in cell motility al-
though no statistically significant differences are apparent in
the rates of cell transmigration across uncoated filters at this
long time point (data not shown). Knockdown of SV alone
shows an upward trend in invasion index (Figure 11), and
reduction of gelsolin alone shows a downward trend that
compares favorably with previously published results (Van
den Abbeele et al., 2007). However, assay-to-assay variances
preclude statistical significance for single knockdowns of
either SV or gelsolin. By contrast, simultaneously reducing
SV and gelsolin significantly decreases the ability of MDA-
MB-231 cells to invade Matrigel-coated filters.
DISCUSSION
We show here that SV reorganizes the cortical actin cytoskel-
eton, stimulating the formation or redistribution of dynamic
basal punctae containing F-actin, cortactin, and other podo-
some/invadopodia proteins while decreasing the extents of
cortactin and lamellipodin at the cell periphery. SV and
cortactin bind directly in vitro and cooperate to redistribute
F-actin in vivo. We also show that SV is a core component of
Src-induced podosomes and invadopodia and that SV con-
tributes to ECM degradation and Matrigel invasion by Src-
expressing MDA-MB-231 breast carcinomas. These results
are consistent with the report that the gene encoding SV,
SVIL, is among the predisposing factors for nonBRCA1/2
(BRCAx) breast cancer (Hedenfalk et al., 2003).
One possible mechanism of SV action is alteration of
signaling pathways upstream of cytoskeletal remodeling.
The earliest change that we see in lamellipodial architecture
in cells expressing EGFP-SV is the loss of peripheral lamel-
lipodin (Figure 5). Lamellipodin regulates actin polymeriza-
Figure 8. Supervillin localizes at and within MDA-MB-231 cell
invadopodia. (A) MDA-MB-231 cells were plated on unlabeled gel-
atin for 3 h, fixed, and stained with antibodies (SV and cortactin)
and/or phalloidin (F-actin) as noted, and then they were imaged by
wide-field microscopy. Merges show supervillin (red), cortactin
(green), and F-actin (blue). Bars, 10 m (top row) and 1 m (bottom
row). (B) MDA-MB-231/WT Src cells were transfected with
mRFP-SV and EGFP-MT1-MMP. Cells were plated on unlabeled
gelatin-coated coverslips for 6 h, fixed, and stained with phalloidin
(F-actin) and imaged by wide-field microscopy. Merges show
mRFP-SV (red), EGFP-MT1-MMP (green), and F-actin (blue). Ar-
rows indicate colocalization; arrowheads denote proximate localiza-
tion. (C) MDA-MB-231 cells were plated on TRITC-labeled gelatin
for 6 h, fixed, and stained with anti-SV antibodies, and then they
were imaged by confocal microscopy as a Z-series with 0.2-m
steps. Merges show supervillin (green) and TRITC-gelatin (red). An
XY view of such a cell is shown (top row). Areas inside the boxes
were enlarged fourfold (second row). Eightfold enlargements of XZ
and YZ views corresponding to a, b, c, and d are shown below XY
views. Bars, 10 m (top row), 5 m (second row), and 1 m (bottom
row).
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tion mediated by Ena/VASP family proteins downstream of
Ras activation (Krause et al., 2004; Jenzora et al., 2005). The
lack of extensive overlap between lamellipodin and SV in
punctae argues against a direct interaction between these
two proteins. However, an indirect negative effect of SV on
lamellipodial organization at the cell periphery could lead to
the loss of broad arcs of peripheral F-actin, cortactin, and
lamellipodin that we observe (Figures 4 and 5).
A second possibility is that SV-induced punctae may rep-
resent podosome/invadopodia “building blocks” associated
with vesicles and/or molecular motors at various stages of
assembly or intracellular transit. SV may help recruit cortac-
tin and F-actin to intracellular membranes. Because SV, cor-
tactin, and filamin all bind F-actin, the lack of filamin re-
cruitment to punctae argues for a selective association with
cortactin. A membrane-based mechanism for SV is likely
based on its intracellular distribution and fractionation be-
havior (Pestonjamasp et al., 1997; Wulfkuhle et al., 1999; Nebl
et al., 2002; Oh et al., 2003; Takizawa et al., 2006). The dot-like
appearances of many EGFP-SV punctae (Figures 1 and 3)
and XY views of endogenous SV at podosomes (Figure 7) are
reminiscent of vesicles, as are the circular profiles that are
occasionally apparent for larger structures associated with
EGFP-SV (Figure 2 and Supplemental Video 1). EGFP-SV/
F-actin/cortactin punctae also resemble cortactin structures
described as occurring before actin recruitment in phorbol
ester-induced podosomes (Webb et al., 2006a) or originating
at lamellipodia and moving in association with endosomes
(Kaksonen et al., 2000; Boguslavsky et al., 2007; Llado´ et al.,
2008). Although we did not detect consistent directional
trafficking of SV punctae from the cell periphery to the
basolateral cell surface, subtle effects on vesicle trafficking or
Figure 9. Overexpression of EGFP-SV increases the number of matrix holes formed per cell. MDA-MB-231/WT Src cells were transfected
with either EGFP alone (A) or EGFP-SV (B) or they were mock transfected (C). Cells were plated on TRITC-labeled gelatin for 6 h before
visualization by green (a) and red (b) fluorescence and phase contrast (d); merged green and red images also are shown (c). Bar, 20 m. (D)
The numbers of holes in the red gelatin matrix (representative of invadopodia) per cell were counted. EGFP-SV cells had a significant (***p
0.001; n 	 8) increase in the number of associated holes per cell. (E) The percentage of cells with some matrix degradation was not
significantly different among the three conditions.
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on cortactin recruitment to transport vesicles could lead to
the observed shift in cortactin and F-actin distribution over
time.
A selective effect of SV on basolateral targeting of cortactin
and MMPs would be consistent both with the observed
effects of SV knockdown on sites of matrix degradation
under the cell center (Figure 10) and with the role of cortac-
tin in MMP trafficking and matrix degradation (Bowden et
al., 1999; Artym et al., 2006; Clark et al., 2007; Clark and
Weaver, 2008). Cortactin recruitment to the ventral cell sur-
face occurs in stages, mediated by at least three convergent
regulatory signals (Artym et al., 2006; Webb et al., 2006a;
Ayala et al., 2008). Activating mechanisms include cortactin
phosphorylation by ERK1/2, Src family kinases, and PAK
(Webb et al., 2006b; Tehrani et al., 2007; Ayala et al., 2008). In
this context, we note that an isoform of SV is involved in
stimulus-mediated activation of ERK1/2 in smooth muscle
(Gangopadhyay et al., 2004) and that SV binds directly to
and regulates myosin II (Takizawa et al., 2007), which di-
rectly affects exocytosis in a number of cell types (Togo and
Steinhardt, 2004). The sequential regulated recruitment of
MMPs and other proteins to invadopodia suggests that sub-
sequent matrix degradation is a dynamic multistep process
(Artym et al., 2006; Clark et al., 2007; Block et al., 2008). Our
SV knockdown results (Figure 10) are consistent with SV-
mediated increases in cortactin activation, enhanced cortac-
tin- or myosin II-mediated MMP secretion, and/or elevation
of the rate of invadopodia turnover.
The decreased matrix degradation generated by knock-
downs of either SV, cortactin, or Tks5 and the colocalization
of all three proteins at SV-induced punctae suggests func-
tional cooperation (Seals et al., 2005; Artym et al., 2006; Clark
et al., 2007; Webb et al., 2007; Ayala et al., 2008; Clark and
Weaver, 2008). Participation in a common pathway is fur-
Figure 10. Underexpression of endogenous
SV decreases the numbers of matrix holes per
cell, especially under the center of the cell.
MDA-MB-231/WT Src cells were transfected
with either control siRNA (Con) or siRNAs tar-
geting SV (SV1 and SV2), the related protein,
gelsolin (Gel), or both SV and gelsolin (SV1/
Gel). These cells were analyzed for protein lev-
els by immunoblotting (A); the percentages of
cells associated with at least one area of de-
graded matrix (hole), relative to control-treated
cells (B); the mean numbers of holes per cell,
relative to control-treated cells (C); and the per-
centages of cells with holes underneath the cell
center (D). The percentages in A denote the
mean levels (n 	 4) of SV and gelsolin, relative
to control-treated cells, after normalization to
the -actin loading control. (B–D) Means  SD;
n 	 6. Asterisks in C and D denote significant
differences (***p  0.001, **p  0.01, and *p 
0.05) from controls in unpaired t tests. (E) Rep-
resentative micrographs of cells treated with
control siRNA (a–c), SV1 siRNA (d–f), or both
SV1 and gelsolin (SV1/Gel) siRNAs (g–i) and
stained for F-actin (a, d, and g) or sites of matrix
degradation (b, e, and h). For merged images (c,
f, and i), holes in the matrix were visualized as
red spots by pseudocoloring the images in b, e,
and h after inverting and thresholding their
luminosities. Note the sites of matrix degrada-
tion at the cell periphery (arrows) and under-
neath the cell center (arrowheads). Overlaps are
yellow or orange. Bar, 20 m.
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ther supported by the interaction of SV with cortactin and by
the decreased formation of EGFP-SV induced F-actin punc-
tae in cortactin knockdown cells (Figure 6). Thus, these
proteins may cooperate in signaling and/or cytoskeletal
organization during invadopodia formation. However, F-
actin structures form at Src-induced podosomes and at the
ventral surfaces of MDA-MB-231 cells after SV knockdown,
arguing for SV-independent effects during initial cytoskel-
etal assembly.
Our results support the hypothesis that SV promotes the loss
of large central focal adhesions (Takizawa et al., 2006) by in-
creasing local matrix degradation. The effects of SV overexpres-
sion on large focal adhesions and on ECM degradation both
represent a gain of function because reduction of endogenous
SV exhibits the opposite phenotype (Takizawa et al., 2006;
Figures 9 and 10). SV targeting to focal adhesions by binding to
TRIP6 (Takizawa et al., 2006) could lead to a loss of underlying
matrix, causing detachment of integrins and thereby inducing
focal adhesion disassembly.
Surprisingly, we find that the outcomes of gelatin degra-
dation experiments with SV and gelsolin (Figure 10) do not
predict the results of Matrigel invasion assays (Figure 11).
This might be due to the fine line between degrading
enough ECM for transmigration versus destroying too much
underlying matrix for the adhesion necessary for movement.
These observations are consistent with the report that down-
regulation of MT1-MMP can actually increase invasion (Par-
tridge et al., 2007). The long time courses of invasion assays
also allow for other mechanisms, such as alterations in cell
motility or proliferation in response to the growth factors
that can be released from Matrigel (Kleinman and Martin,
2005). Commonalities in signaling mechanisms could ex-
plain the functional redundancy between SV and gelsolin
during Matrigel invasion, especially if SV can recruit actin to
membranes enriched in phosphatidylinositol bisphosphate,
as suggested by the similarities between SV and gelsolin
sequences involved in this process (Hartwig et al., 1989;
Mere et al., 2005). Gelsolin and CapG, another member of the
villin/gelsolin family, also synergize with each other during
matrix invasion and have each been implicated in multiple
stages of tumorigenesis (Dong et al., 1999; Lee et al., 1999;
Silacci et al., 2004; Watari et al., 2006; Kim et al., 2007; Van den
Abbeele et al., 2007; Nomura et al., 2008). We conclude that
SV plays a nonredundant role in ECM degradation by
MDA-MB-231 breast carcinoma cells and has a function
overlapping that of gelsolin during invasion, both of which
are important facets of tumor cell migration and metastasis.
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